Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 59   

Articles published

AZN 4,572.50 +123.50 (2.78%)
price chart
AstraZeneca to Buy Back $4.5 Billion in Stock, Cut Jobs as Patents Expire
AstraZeneca Plc (AZN), the U.K.'s second- biggest drugmaker, fell the most in five months after saying profit this year will decline as the company prepares to face generic competition to top-selling medicines.
AstraZeneca closing Montreal R&D plant  Globe and Mail
AstraZeneca to cut 7300 jobs worldwide  DigitalJournal.com
Related articles »  
Europe Job Losses Accelerate With AstraZeneca-to-PepsiCo Firing Employees
Global companies from NEC Corp. (6701) to PepsiCo Inc. (PEP) and AstraZeneca Plc (AZN) are chopping jobs more than three times faster than in 2011 as they brace for recession in Europe and a slowdown in China.
Related articles »  
Pfizer, AstraZeneca face revenue drop as patent protection expires
Pfizer Canada Inc. lost its bid to block the production of a generic eye drug by Apotex Inc. when the Supreme Court of Canada declined Thursday to hear the company's appeal.
Related articles »  
Making the right exit: Lessons learned from AstraZeneca and IBM
The MSA also contained an obligation on AstraZeneca to produce an IT transfer plan for IBM detailing how the services would be transferred away from IBM.
Related articles »  
AstraZeneca Loses Ruling Over 2018 and 2021 Crestor Patents
AstraZeneca Plc (AZN) lost a U.S. appeals court bid to protect its best-selling drug, Crestor, from generic competition until as late as 2021.
Related articles »  
AstraZeneca India job cuts likely to hurt drug research
New Delhi: Theextensive layoffs at London-listed drug maker AstraZeneca Plc's research outfits have hit India. On 13 February, the firm's Bangalore subsidiary laid off 19 employees�15 of them middle-level and senior scientists involved in the research ...
Related articles »  
Vodafone and Visa announce global tie-up
What This Top Dividend Portfolio Is Holding Now: AstraZeneca plc, HSBC Holdings plc And Vodafone Group plc. 16/12/2014. Will BT Group plc Leapfrog Vodafone Group plc With EE Mobile Takeover?
Related articles »  
European, U.S. Futures Rise as Asian Shares Gain; Deutsche Bank May Fall
AstraZeneca Plc (AZN) sank 3.4 percent after saying 2012 will be challenging for the industry. The Stoxx Europe 600 Index rose 0.2 percent to 260.11 at the close for the gauge's highest level since Aug. 1. The benchmark measure swung between gains and ...
Related articles »  
GlaxoSmithKline: why I like this 'big and boring' share
I return to the topic of GlaxoSmithKline (GSK.L) following its 2011 results and because I am thinking of buying it for the �10,000 portfolio based on Citywire Top Stocks�.
Related articles »  
Should you join the savers turning to income fund investing for better returns?
Generating half-decent income from savings is proving an impossibility as interest rates remain stubbornly low and banks and building societies squeeze returns.
Related articles »